Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Insights into Imaging
Published in: Insights into Imaging 4/2015

Open Access 01-08-2015 | Review

Primary fallopian tube carcinoma: review of MR imaging findings

Authors: Filipe Veloso Gomes, João Lopes Dias, Rita Lucas, Teresa Margarida Cunha

Published in: Insights into Imaging | Issue 4/2015

Login to get access

Abstract

Objectives

To review the epidemiological and clinical features of primary fallopian tube carcinoma (PFTC), and to illustrate the spectrum of MRI findings, with pathological confirmation.

Methods

This article reviews the relevant literature on the epidemiological, clinical, and imaging features of primary fallopian tube carcinoma, with pathological confirmation, using illustrations from the authors’ teaching files.

Results

Primary fallopian tube carcinoma came under focus over the last few years due to its possible role on the pathogenesis of high-grade serous epithelial ovarian and peritoneal cancers. Typical symptoms, together with the presence of some of the most characteristic MRI signs, such as a “sausage-shaped” pelvic mass, hydrosalpinx, and hydrometra, may signal the presence of primary fallopian cancer, and allow the radiologist to report it as a differential diagnosis.

Conclusions

Primary fallopian tube carcinoma has a constellation of clinical symptoms and magnetic resonance imaging features, which may be diagnostic. Although these findings are not present together in the majority of cases, radiologists who are aware of them may include the diagnosis of primary fallopian tube cancer in their report more frequently and with more confidence.

Teaching Points

• PFTC may be more frequent than previously thought
• PFTC has specific clinical and MRI characteristics
• Knowledge of typical PFTC signs enables its inclusion in the differential diagnosis
• PFTC is currently staged under the 2013 FIGO system
• PFTC is staged collectively with ovarian and peritoneal neoplasms
Literature
1.
2.
Rezvani M, Shaaban AM (2011) Fallopian tube disease in the nonpregnant patient. RadioGraphics 31:527–548PubMedCrossRef
3.
Shaaban AM, Rezvani M (2012) Imaging of primary fallopian tube carcinoma. Abdom Imaging 38:608–618CrossRef
4.
Alvarado-Cabrero I, Stolnicu S, Kiyokawa T et al (2013) Carcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 127 patients with evaluation of staging and prognostic factors. Ann Diagn Pathol 17:159–164PubMedCrossRef
5.
Riska A, Leminen A, Pukkala E (2003) Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953-97. Int J Cancer 104:643–645PubMedCrossRef
6.
Goodman MT, Shvetsov YB (2009) Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004. Cancer Epidemiol Biomarkers Prev 18:132–139PubMedCentralPubMedCrossRef
7.
Nik NN, Vang R, Shih I-M, Kurman RJ (2014) Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma. Annu Rev Pathol Mech Dis 9:27–45CrossRef
8.
Chan A, Gilks B, Kwon J, Tinker AV (2012) New insights into the pathogenesis of ovarian carcinoma. Obstet Gynecol 120:935–940PubMedCrossRef
9.
10.
Reitsma W, de Bock GH, Oosterwijk JC et al (2013) Support of the “fallopian tube hypothesis” in a prospective series of risk-reducing salpingo-oophorectomy specimens. Eur J Cancer 49:132–141PubMedCrossRef
11.
Dietl J (2013) Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube. Arch Gynecol Obstet 289:241–246PubMedCrossRef
12.
Zheng W, Fadare O (2012) Fallopian tube as main source for ovarian and pelvic (Non-endometrial) serous carcinomas. Int J Clin Exp Pathol 5(3):182–186PubMedCentralPubMed
13.
Seidman JD, Zhao P, Yemelyanova A (2011) “Primary peritoneal” high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer. Gynecol Oncol 120:470–473PubMedCrossRef
14.
Callahan MJ, Crum CP, Medeiros F et al (2007) Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 25:3985–3990PubMedCrossRef
15.
16.
Vang R, Shih I-M, Kurman RJ (2012) Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. Histopathology 62:44–58CrossRef
17.
Berek JS, Crum C, Friedlander M (2012) Cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 119(Suppl 2):S118–S129PubMedCrossRef
18.
Chêne G, Dauplat J, Radosevic-Robin N et al (2013) The fallopian tube odyssey: from the ovary to the tube. About high-grade serous ovarian carcinoma. Bull Cancer 100:757–764PubMed
19.
Horn L-C, Kafkova S, Leonhardt K et al (2013) Serous Tubal in Situ Carcinoma (STIC) in primary peritoneal serous carcinomas. Int J Gynecol Pathol 32:339–344PubMedCrossRef
20.
Lau H-Y, Chen Y-J, Yen M-S et al (2013) Primary fallopian tube carcinoma: a clinicopathologic analysis and literature review. J Chin Med Assoc 76:583–587PubMedCrossRef
21.
Slanetz PJ, Whitman GJ, Halpern EF et al (1997) Imaging of fallopian tube tumors. AJR Am J Roentgenol 169:1321–1324PubMedCrossRef
22.
23.
Kawakami S, Togashi K, Kimura I et al (1993) Primary malignant tumor of the fallopian tube: appearance at CT and MR imaging. Radiology 186:503–508PubMedCrossRef
24.
Outwater EK, Siegelman ES, Chiowanich P et al (1998) Dilated fallopian tubes: MR imaging characteristics. Radiology 208:463–469PubMedCrossRef
25.
Ghattamaneni S, Bhuskute NM, Weston MJ, Spencer JA (2009) Discriminative MRI features of fallopian tube masses. Clin Radiol 64:815–831PubMedCrossRef
26.
Kim MY, Rha SE, Oh SN et al (2009) MR imaging findings of hydrosalpinx: a comprehensive review1. RadioGraphics 29:495–507PubMedCrossRef
27.
Haratz-Rubinstein N, Russell B, Gal D (2004) Sonographic diagnosis of fallopian tube carcinoma. Ultrasound Obstet Gynecol 24:86–88PubMedCrossRef
28.
Kalampokas E, Kalampokas T, Tourountous I (2013) Primary fallopian tube carcinoma. Eur J Obstet Gynecol Reprod Biol 169(2):155–161PubMedCrossRef
29.
Riska A, Martinsen JI, Kjaerheim K et al (2011) Occupation and risk of primary fallopian tube carcinoma in Nordic countries. Int J Cancer 131:186–192PubMedCrossRef
30.
Ajithkumar TV, Minimole AL, John MM, Ashokkumar OS (2005) Primary fallopian tube carcinoma. Obstet Gynecol Surv 60:247–252PubMedCrossRef
31.
Horng HC, Teng SW, Huang BS et al (2014) Primary fallopian tube cancer: domestic data and up-to-date review. Taiwan J Obstet Gynecol 53(3):287–292PubMedCrossRef
32.
33.
34.
Hefler LA, Rosen AC, Graf AH et al (2000) The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: a multicenter study. Cancer 89:1555–1560PubMedCrossRef
35.
WHO Classification of Tumours of Female Reproductive Organs (2014). In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH, World Health Organization, 4th Edn. Lyon
36.
Gadducci A, Landoni F, Sartori E et al (2001) Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a Cooperation Task Force (CTF) study. Gynecol Oncol 81:150–159PubMedCrossRef
37.
Hu CY, Taymor ML, Hertig AT (1950) Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 59:58–67, illust PubMed
38.
39.
Sedlis A (1978) Carcinoma of the fallopian tube. Surg Clin North Am 58:121–129PubMed
40.
Singh N, Gilks CB, Wilkinson N, McCluggage WG (2014) Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal. Histopathology 65:149–154PubMedCrossRef
41.
Aich RK, Dasgupta S, Chakraborty B et al (2012) Primary fallopian tube carcinoma with metastasis in the contralateral ovary. J Indian Med Assoc 110:494–5, 498
42.
Prat J (2014) Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 124:1–5PubMedCrossRef
43.
Kosary C, Trimble EL (2002) Treatment and survival for women with fallopian tube carcinoma: a population-based study. Gynecol Oncol Aug 86(2):190–191CrossRef
44.
di Re E, Grosso G, Raspagliesi F, Baiocchi G (1996) Fallopian tube cancer: incidence and role of lymphatic spread. Gynecol Oncol 62:199–202PubMedCrossRef
45.
Morgan R. NCCN Clinical practice guidelines in oncology. Ovarian cancer. Version 3.2014
46.
Usach I, Blansit K, Chen L-M et al (2015) Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas. Am J Obstet Gynecol 212:188.e1–6PubMedCrossRef
47.
Moore KN, Moxley KM, Fader AN et al (2007) Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary. Gynecol Oncol 107:398–403PubMedCrossRef
48.
49.
Kol S, Gal D, Friedman M, Paldi E (1990) Preoperative diagnosis of fallopian tube carcinoma by transvaginal sonography and CA-125. Gynecol Oncol 37:129–131PubMedCrossRef
50.
Arko D, Žegura B, Virag M et al (2014) Preoperative diagnosis of fallopian tube malignancy with transvaginal color doppler ultrasonography and magnetic resonance imaging after negative hysteroscopy for postmenopausal bleeding. Coll Antropol 38:1047–1050
51.
Hosokawa C, Tsubakimoto M, Inoue Y, Nakamura T (2006) Small fallopian tube carcinoma with extensive upper abdominal dissemination: a case report. AJR Am J Roentgenol 186:1046–1050PubMedCrossRef
52.
Spencer JA, Forstner R, Cunha TM et al (2010) ESUR guidelines for MR imaging of the sonographically indeterminate adnexal mass: an algorithmic approach. Eur Radiol 20:25–35PubMedCrossRef
53.
Anthoulakis C, Nikoloudis N (2014) Pelvic MRI as the “gold standard” in the subsequent evaluation of ultrasound-indeterminate adnexal lesions: a systematic review. Gynecol Oncol 132:661–668PubMedCrossRef
54.
Nishino M, Hayakawa K, Minami M et al (2003) Primary retroperitoneal neoplasms: CT and MR imaging findings with anatomic and pathologic diagnostic Clues1. RadioGraphics 23:45–57PubMedCrossRef
55.
Metadata
Title
Primary fallopian tube carcinoma: review of MR imaging findings
Authors
Filipe Veloso Gomes
João Lopes Dias
Rita Lucas
Teresa Margarida Cunha
Publication date
01-08-2015
Publisher
Springer Berlin Heidelberg
Published in
Insights into Imaging / Issue 4/2015
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1007/s13244-015-0416-y

Other articles of this Issue 4/2015

Insights into Imaging 4/2015 Go to the issue

Review

False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillance

Statement

ESR Position Paper on Imaging Biobanks

Opinion

Imaging patients with renal colic—consider ultrasound first

Pictorial Review

Multidetector CT imaging of complications after laparoscopic nephron-sparing surgery

Report

Summary of the European Directive 2013/59/Euratom: essentials for health professionals in radiology

Pictorial Review

Spectrum of Imaging Findings in Paget’s Disease of the Breast—A Pictorial Review